Introduction
Specialty palliative care (PC) improves quality-of-life and end-of-life care for patients with acute myeloid leukemia (AML) (1), but workforce shortages (2) and oncology perceptions (3,4) complicate the delivery of specialty PC to all patients with AML. An alternative strategy includes training oncology clinicians to incorporate PC skills into their care practice (“primary PC”). Primary PC improves patient outcomes (5,6), but clinician perspectives and clinical culture toward primary PC are unknown.
Methods
From 02/2024-11/2024, we conducted a baseline cross-sectional survey of leukemia and PC clinicians across 20 healthcare institutions participating in a large-scale trial of specialty versus primary PC for patients hospitalized with AML. The survey measured perceptions toward PC for patients with AML. We analyzed survey results descriptively.
Results
Overall, 189/468 (40%) leukemia and 251/480 (52%) PC clinicians responded to the survey. Few leukemia clinicians agreed they have sufficient training (43%) and time (23%) to address PC needs of patients with AML, while most PC clinicians agreed with the same statements (71%, 74%). Most leukemia clinicians agreed that oncologists should be experts in physical (90%) and psychological (73%) symptom management and direct care coordination for patients with AML at all disease stages (74%). Most PC clinicians agreed oncologists should be experts in physical symptom management (77%), but only about half agreed oncologists should be experts in psychological symptom management (56%) and direct care coordination for patients with AML at all disease stages (54%). Most leukemia clinicians perceived openness to integrate PC (72%) and agreement on the importance of PC (79%) among their oncology peers, while few PC clinicians perceived openness to integrate PC (42%) and agreement on the importance of PC (39%) from their oncology peers. Most leukemia clinicians perceived commitment (68%) and championing (53%) of PC by oncology leaders, while few PC clinicians perceived commitment (38%) and championing (40%) of PC by oncology leaders.
Conclusions
Leukemia and PC clinicians differed in perceptions of oncology leadership support, collaboration, and ownership over PC topics. These cultural differences pose potential barriers to the implementation of PC interventions for patients with AML. Future research will examine clinician perceptions over time as their institutions participate in a PC trial.
Tables and Figures

Figure 1
References
El-Jawahri A, LeBlanc TW, Kavanaugh A, Webb JA, Jackson VA, Campbell TC, et al. Effectiveness of integrated palliative and oncology care for patients with acute myeloid leukemia: A randomized clinical trial. JAMA Oncol. 2021 Feb 1;7(2):238–45.
Hui D, Elsayem A, De la Cruz M, Berger A, Zhukovsky DS, Palla S, et al. Availability and integration of palliative care at US cancer centers. JAMA. 2010 Mar 17;303(11):1054–61.
Hui D, Park M, Liu D, Reddy A, Dalal S, Bruera E. Attitudes and beliefs toward supportive and palliative care referral among hematologic and solid tumor oncology specialists. Oncologist. 2015 Nov;20(11):1326–32.
El-Jawahri A, LeBlanc TW, Burns LJ, Denzen E, Meyer C, Mau L-W, et al. What do transplant physicians think about palliative care? A national survey study. Cancer. 2018 Dec 1;124(23):4556–66.
Bernacki R, Paladino J, Neville BA, Hutchings M, Kavanagh J, Geerse OP, et al. Effect of the serious illness care program in outpatient oncology: A cluster randomized clinical trial. JAMA Intern Med. 2019 Jun 1;179(6):751–9.
Paladino J, Bernacki R, Neville BA, Kavanagh J, Miranda SP, Palmor M, et al. Evaluating an Intervention to Improve Communication Between Oncology Clinicians and Patients With Life-Limiting Cancer: A Cluster Randomized Clinical Trial of the Serious Illness Care Program. JAMA Oncol. 2019 Jun 1;5(6):801–9.